Eilean Therapeutics AU Pty Ltd

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Tolerability of ZE74-0282 in Healthy Volunteers	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, leukemia, myeloid leukemia, neoplasm, polycythemia, primary myelofibrosis, thrombocytosis disease	Recruiting	Phase 1	2026-07-28		NCT07527221

Clinical trials